Hidalgo-Vega, Álvaro; Ramos-Goñi, Juan; Villoro, Renata - In: The European Journal of Health Economics 15 (2014) 9, pp. 917-925
Ranolazine is a highly efficient add-on therapy for the symptomatic treatment of chronic angina pectoris in patients who are inadequately controlled by, or intolerant to, first-line antianginal therapies in Spain. </AbstractSection> Copyright Springer-Verlag Berlin Heidelberg 2014